Product Images Losartan Potassium

This is a brief report on a study that compares the effectiveness of Atenolol and Losartan potassium in reducing the primary endpoint in patients. The study lasted for 66 months and seems to have shown that Losartan potassium was slightly more effective, with an adjusted risk reduction rate of 13% (compared to Atenolol) and a p-value of 0.021. The graph shows the study months on the x-axis and there is no additional information available to further explain the primary endpoint.*

The text provides information about the effectiveness of two medications, Atenolol and Losarten potassium, in reducing the risk of fatal and non-fatal stroke. The data shows an adjusted risk reduction of 25% with a p-value of 0.001. The chart displays the percentage of patients with stroke at various intervals over a period of 66 months.*

This appears to be a table showing the results of a study comparing the effectiveness of Losartan K and Atenolol in reducing the risk of stroke (fatal or non-fatal) in a sample population. The table gives the number of participants, percentage of stroke events, and other relevant details such as age, gender, race, diabetes status, and history of CVD. The symbols are said to be proportional to the sample size. The study appears to suggest that Losartan K may be more effective than Atenolol, but further details cannot be derived from the given text.*

This is a graph showing the percentage of patients with an event related to Losartan Potassium and Placebo. The Risk Reduction is indicated to be at 16.1% with a p-value of 0.022. However, without more context, it is not clear what type of event is being referred to or what the numbers on the graph represent.*

This text represents the name of a company called UWNICHEM Pharmaceuticals (USA), Inc.*

This text indicates the company name "UNICHEM PHARMACEUTICALS (USA). INC." It does not provide any further information that could be used to describe the company or its products.*

Each tablet contains 25 mg of Losartan potassium, USP. This medication is used to treat high blood pressure and to help protect the kidneys from damage due to diabetes. The usual dosage should be determined by the accompanying package insert or as directed by a healthcare professional. Store at room temperature between 10-25°C (77°F). Keep the container tightly closed and protect from light. This drug should be kept out of reach of children. The tablets are manufactured by Unichem Laboratories Ltd. in Ghaziabad, India, and are distributed in the US by Unichem Pharmaceuticals (USA) Inc. in East Brunswick, NJ. Only 30 tablets are included in each package.*

This is a medication label for Losartan Potassium tablets containing 50mg. The usual dosage is not provided, though directions can be found on an accompanying package insert. The medication should be stored at controlled room temperature and kept away from reach of children. The manufacturer is Unichem Laboratories LTD and the medication is dispensed by a pharmacist with a patient information leaflet. These specific tablets were manufactured for Unichem Pharmaceuticals (USA), INC.*

Losartan Potassium is a medication with a strength of 100mg per tablet. The recommended dosage of Losartan Potassium is not available. The tablets should be stored between 10°C-25°C. Only 30 tablets are included. The drug is manufactured by Unichem Laboratories LTD and is manufactured for Unichem Pharmaceuticals (USA) Inc. The package does not include patient information leaflet but it should be dispensed by a pharmacist. The product should be kept away from children and the package has a NDC number of 29300-146-13.*